Compounds > 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidinyl)-1-nitrosourea
Page last updated: 2024-08-22

1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidinyl)-1-nitrosourea and Anemia

1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidinyl)-1-nitrosourea has been researched along with Anemia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Korsmeyer, SJ; Luc, PV; Rahman, A; Schein, PS; Smith, FP; Woolley, PV1

Other Studies

1 other study(ies) available for 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidinyl)-1-nitrosourea and Anemia

ArticleYear
Phase I trial and clinical pharmacology of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea.
    Cancer research, 1981, Volume: 41, Issue:10

    Topics: Anemia; Drug Evaluation; Half-Life; Humans; Kinetics; Leukopenia; Middle Aged; Mustard Compounds; Neoplasms; Nitrosourea Compounds; Protein Binding; Thrombocytopenia

1981